[Today's headlines]

Guangdong adjusts medical and aesthetic surgery programs. Cosmetic surgery can be treated with injectable programs such as hyaluronic acid

On May 21, the Guangdong Provincial Health Commission issued an adjustment notice for medical aesthetic surgery programs. According to the notice, physical therapy and injection treatment have been added to the cosmetic surgery level 1 program “(4) Others”. Among them, physical therapy includes laser therapy, intense pulsed light (IPL) treatment, radiofrequency therapy, photodynamic therapy, ultrasound therapy, microneedle therapy, and line techniques for tissue lifting and contraction; injection treatment includes vitriase injections, scar injections, mesotherapy injections, hardener injections, intradermal drug injections, and injections of fillers such as hyaluronic acid, collagen, polylactic acid, and polydilactic acid.

Some analysts pointed out that cosmetic surgery can include injectable programs such as hyaluronic acid, which may be beneficial to the hyaluronic acid race track, or will further boost hyaluronic acid consumption. According to the “China Hyaluronic Acid Industry Market Outlook and Investment Strategy Planning Analysis Report” released by the Forward-looking Industry Research Institute, injectable projects account for 31.7% of non-surgical medical and aesthetic projects; it is estimated that by 2026, China's hyaluronic acid market will reach 12.7 billion yuan, with a compound annual growth rate of about 14.18%. It involves Hong Kong stocks Haohai Biotechnology (06826) and Sihuan Pharmaceutical (00460).

[General outlook]

The market is concerned about Nvidia's earnings report and the minutes of the Federal Reserve meeting

Overnight, the Dow rose 66.22 points, or 0.17%, to 39872.99 points; the NASDAQ rose 37.75 points, or 0.22%, to 16832.62 points; and the S&P 500 rose 13.28 points, or 0.25%, to 5321.41 points. Microsoft (MSFT.US) rose 0.87%, Apple (AAPL.US) rose 0.69%, Nvidia (NVDA.US) rose 0.64%, and Xiaopeng Motors (XPEV.US) rose nearly 6%.

The market is watching the upcoming Nvidia earnings report and the minutes of the Federal Reserve meeting.

[Hot preview]

National Health Insurance Administration: Selected prices for joint prosthesis procurement have declined steadily, with an average drop of about 6%

An official from the National Health Insurance Administration reported that recently, the National Health Insurance Administration organized all provinces across the country to continue procurement after the expiration of the artificial joint collection agreement, and tenders were opened in Tianjin on May 21. More than 6,000 hospitals participated in this follow-up procurement, reporting a demand of 580,000 units, a slight increase over the first round of collection, including 286,000 hip units and 294,000 knee sets. Compared with the results of the first round of collection, the selected prices for this successive procurement have declined steadily, with an average drop of about 6%, achieving the goal of stabilizing collection results and ensuring long-term benefits for the public. The artificial joint industry involves Hong Kong stocks of Minimally Invasive Medicine (00853), Elken Healthcare (01789), Chunli Healthcare (01858), and Weigao (01066).

Starting June 1, IVF in Shanghai will be reimbursed by medical insurance

The reporter learned from the Shanghai Municipal Health Insurance Bureau that in order to implement active maternity support measures, the Municipal Health Insurance Bureau, together with social welfare and health departments, recently issued the “Notice on Including Some Therapeutic Assisted Reproduction Technology Projects in the Scope of Medical Insurance and Work Injury Insurance Payments”. Starting June 1 of this year, 12 assisted reproduction medical service programs such as “egg retrieval” will be included in the scope of medical insurance payments. Earlier, the Municipal Health Insurance Bureau regulated the current assisted reproduction medical service programs in Shanghai and optimized and integrated them into 17 assisted reproduction medical service programs, including “egg retrieval.” Among them, 12 projects are included in the scope of medical insurance payments in Shanghai, covering essential medically assisted reproduction techniques such as egg retrieval, sperm extraction, artificial insemination, embryo culture, and embryo transfer. Hong Kong stocks related to the assisted reproduction concept include Jinxin Reproduction (01951).

Gaoxin Retail (06808) announces annual results, loss attributable to shareholders of $1,605 billion, year-on-year profit to loss, and proposed final dividend of HK$0.02 per share

According to the Zhitong Finance App, Gaoxin Retail (06808) announced financial results for the year ended March 31, 2024. The group achieved revenue of 72,567 billion yuan (RMB, same below) during the period, a year-on-year decrease of 13.3%; loss attributable to shareholders was $1,605 billion, profit attributable to shareholders during the same period last year, profit of $109 million, year-on-year profit and loss; basic loss of $0.17 per share; proposed final dividend of HK$0.02 per share.

BOSS Direct Hiring - W (02076) all financial indicators for the first quarter exceeded expectations, adjusted net profit of about 531 million yuan, an increase of 116.6% year-on-year

According to the Zhitong Finance App, BOSS Direct Employment-W (02076) announced results for the first quarter of 2024, with revenue of RMB 1,703.8 billion, an increase of 33.4% over the previous year. Net profit was RMB 241.7 million, an increase of 6.4 times over the previous year. Adjusted net profit was approximately RMB 531 million, an increase of 116.6% year over year. Net profit of $0.28 per common share. The average number of monthly active users was 46.6 million, an increase of 17.4% over the previous year. The total number of paying corporate customers for the 12 months ended March 31, 2024 was 5.7 million, an increase of 42.5% over the 4 million in the 12 months ended March 31, 2023.

China Aviation Science and Industry (02357): Qianshan Electronics will cash out about 659 million yuan in assets sold to the aviation industry

According to the Zhitong Finance App, China Aviation Technology and Industry (02357) announced that in order to further optimize resource allocation and revitalize existing assets, on May 21, 2024, the company and China Aviation Airborne Board approved the asset transaction contract between Qianshan Electronics and Aviation Industry Computing. Qianshan Electronics will sell target assets to Aviation Industry Computing for a consideration of approximately RMB 659 million. The group is expected to confirm revenue of approximately RMB 659.474 million as a result of the sale. On the date of this announcement, Qianshan Electronics is a wholly-owned subsidiary of China Aviation Aircraft Corporation (a non-wholly-owned subsidiary of the company).

China Mobile (00941) plans to pay a final dividend of HK$2.40 per share

According to Zhitong Finance App, China Mobile (00941) announced that the company plans to hold the 2024 Annual General Meeting of Shareholders on May 22, 2024 to review the “Proposal on the Company's 2023 Profit Distribution Plan and Announce the Payment of Final Dividends”. The Board recommended a dividend payout rate of 71% for the full year of 2023, with a final dividend of HK$2.40 per share (tax included) for the year ended December 31, 2023. The dividend will be denominated and declared in HKD. The dividend for A shares will be paid in RMB, and the converted exchange rate is calculated based on the average median price of HK$1 per share announced by the People's Bank of China the week before the annual shareholders' declaration of dividends, equivalent to RMB 0.910394 (tax included).

Xiaopeng Motor-W (09868)'s total revenue for the first quarter was 6.55 billion yuan, up 62.3% year on year

According to the Zhitong Finance App, Xiaopeng Automobile-W (09868) announced that in the first quarter of 2024, total revenue was 6.55 billion yuan (RMB, same unit), up 62.3% year on year and down 49.8% from the fourth quarter of 2023; automobile sales revenue was 5.54 billion yuan, up 57.8% year on year, and down 54.7% from the fourth quarter of 2023; gross profit margin was 12.9%, compared with 6.2% in the fourth quarter of 2023.

Eagle Hitomi Technology-B (02251) and Beijing Haidian District launch the “Artificial Intelligence Fundus Diagnosis and Treatment Collaboration Platform”

The Zhitong Finance App learned that on April 22, under the guidance of the Beijing Haidian District Health Commission and Zhongguancun Science City, Eagle Eye Technology-B (02251) and 48 primary medical institutions in Haidian District jointly launched the construction of an “Artificial Intelligence Eye Diagnosis and Treatment Collaboration Platform”. This platform is not only the first example of privatization deployment in a medical consortium region in the country, but its integrated AI technology will greatly enhance general collaboration capabilities.

Tongcheng Travel (00780) announced first-quarter results, adjusted net profit increased 10.9% year over year to 559 million yuan Average monthly paying users increased 2.9% year over year to 42.6 million

According to Zhitong Finance App News, Tongcheng Travel (00780) announced the results for the three months ended March 31, 2024. The group achieved revenue of 3.866 billion yuan (RMB, same below) during the period, up 49.5% year on year; adjusted EBITDA increased 12% year on year to 820 million yuan; adjusted net profit increased 10.9% year on year to 559 million yuan; average monthly paying users increased 2.9% year on year to 42.6 million people.

[Individual stocks are a bit clear]

Eneng Logistics (09956): Adjusted net profit of about 209 million yuan in the first quarter increased 173.9% year on year

According to the Zhitong Finance App, Eneng Logistics (09956) announced results for the first quarter of 2024, with revenue of about 2,378 billion yuan, an increase of 15.2% over the previous year. Gross profit was approximately 382 million yuan, an increase of 77.6% year over year. The profit attributable to the owner of the parent company was approximately 188 million yuan, an increase of 3.26 times over the previous year. Adjusted net profit was approximately $209 million, up 173.9% year on year.

In the three months ended March 31, 2024, the company has completed a total freight volume of 2,875 thousand tons. The total freight volume in 2023 was 2,362 thousand tons, an increase of 21.7% over the previous year. This is due to the optimization of the network structure of the company's freight partners and agents and the increase in average cargo volume.

By the end of March 2024, the company had more than 6,400 freight partners and more than 23,000 freight forwarders. By the end of March 2023, the company had more than 5,800 freight partners and more than 23,000 freight forwarders, and by the end of December 2023, it had more than 5,900 freight partners and more than 22,000 freight forwarders, enabling the company to better serve end customers as it continues to expand its national coverage.